Location History:
- Kumagaya, JP (1995)
- Tokyo, JP (1996 - 2008)
Company Filing History:
Years Active: 1995-2008
Title: Toshi Komurasaki - Innovator in Monoclonal Antibody Development
Introduction
Toshi Komurasaki, a prominent inventor based in Tokyo, Japan, has made significant strides in the field of biotechnology. He holds four patents, showcasing his dedication and innovative approach to scientific research and development. His work has contributed to advancing detection methods for human tumors, with a focus on monoclonal antibodies.
Latest Patents
Komurasaki's latest patent, titled "Monoclonal antibody and hybridoma producing the same," establishes a simple and highly sensitive method for detecting human epiregulin (hEPR). This invention not only enhances early detection of human tumors expressing hEPR but also provides a novel diagnostic tool in the medical field. The patent includes a specific monoclonal antibody that recognizes hEPR and the hybridoma that produces it, showcasing his expertise in developing critical medical technologies.
Career Highlights
Toshi Komurasaki is currently associated with Taisho Pharmaceutical Co., Ltd., where he utilizes his extensive knowledge to contribute to the company’s innovative projects. His career has been marked by a commitment to improving patient outcomes through scientific innovation. His four patents reflect a blend of technical skill and a passion for research aimed at addressing current medical challenges.
Collaborations
Throughout his impressive career, Komurasaki has collaborated with esteemed colleagues such as Hitoshi Toyoda and Kazunori Hanada. These collaborations have not only advanced his research but have also fostered a rich environment of shared knowledge and innovation within the company. Working alongside these talented individuals has allowed for the exchange of ideas that propels their collective research efforts forward.
Conclusion
In conclusion, Toshi Komurasaki stands out as a significant figure in the field of biotechnology, particularly in the development of monoclonal antibodies. His contributions at Taisho Pharmaceutical Co., Ltd. and his innovative patents continue to play a crucial role in the advancement of medical diagnostics, positively impacting the lives of many individuals. His journey of invention and collaboration exemplifies the spirit of innovation, paving the way for future breakthroughs in medical science.